Patents by Inventor Barbara Ellers-Lenz

Barbara Ellers-Lenz has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • DRUG FOR TREATMENT OF TINNITUS PATIENTS
    Publication number: 20170049717
    Abstract: A drug for treatment of patients having tinnitus associated with sudden hearing loss, comprising neramexane or a pharmaceutically acceptable salt thereof, wherein the morbidity period of the patient having tinnitus associated with sudden hearing loss is 48 months or longer.
    Type: Application
    Filed: April 27, 2015
    Publication date: February 23, 2017
    Applicant: KYORIN PHARMACEUTICAL CO., LTD.
    Inventors: Yoshifumi HIRAHARA, Shinji NAGAI, Ai USHIWATA, Ikuyo NIWAYAMA, Koichi WATANABE, Madoka TOMINAGA, Takafumi KUROSE, Shinichi YAMADA, Takehiro SHINOZAKI, Janos CSIKOS, Roman GORTELMEYER, Barbara ELLERS-LENZ, Michael ALTHAUS, Ulli BANKSTAHL
  • 1-AMINOCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF COCHLEAR TINNITUS
    Publication number: 20170027885
    Abstract: The present invention relates to the treatment of an individual afflicted with tinnitus associated with hearing loss comprising administering to the individual an effective amount of a 1-amino-alkylcyclohexane derivative.
    Type: Application
    Filed: October 12, 2016
    Publication date: February 2, 2017
    Inventors: Barbara Ellers-Lenz, Tanja Rosenberg, Hagen Krüger, Michael Althaus
  • 1-aminocyclohexane derivatives for the treatment of cochlear tinnitus
    Patent number: 9498450
    Abstract: The present invention relates to the treatment of an individual afflicted with cochlear tinnitus comprising administering to the individual an effective amount of a 1-amino-alkylcyclohexane derivative.
    Type: Grant
    Filed: September 10, 2008
    Date of Patent: November 22, 2016
    Assignee: MERZ PHARMA GmbH & CO. KGaA
    Inventors: Barbara Ellers-Lenz, Tanja Rosenberg, Hagen Kruger, Michael Althaus
  • TITRATION PACKAGE FOR NERAMEXANE AND ITS USE IN THE TREATMENT OF AN INNER EAR DISORDER
    Publication number: 20150018425
    Abstract: The present invention relates to a titration scheme for the administration of a 1-amino-alkylcyclohexane derivative which allows for quick attainment of an effective dose of a 1-amino-alkylcyclohexane derivative while minimizing side effects. The present invention further relates to a titration package for providing a 1-amino-alkylcyclohexane derivative (e.g., neramexane or a pharmaceutically acceptable salt thereof) in at least two different dosages. The present titration scheme/titration package may be useful in the treatment of various diseases, including tinnitus.
    Type: Application
    Filed: September 30, 2014
    Publication date: January 15, 2015
    Inventors: Barbara ELLERS-LENZ, Tanja ROSENBERG, Erhard SEILLER, Hagen KRÜGER, Michael ALTHAUS
  • Titration package for neramexane and its use in the treatment of an inner ear disorder
    Patent number: 8877814
    Abstract: The present invention relates to a titration scheme for the administration of a 1-amino-alkylcyclohexane derivative which allows for quick attainment of an effective dose of a 1-amino-alkylcyclohexane derivative while minimizing side effects. The present invention further relates to a titration package for providing a 1-amino-alkylcyclohexane derivative (e.g., neramexane or a pharmaceutically acceptable salt thereof) in at least two different dosages. The present titration scheme/titration package may be useful in the treatment of various diseases, including tinnitus.
    Type: Grant
    Filed: September 10, 2008
    Date of Patent: November 4, 2014
    Assignee: Merz Pharma GmbH & Co. KGaA
    Inventors: Barbara Ellers-Lenz, Tanja Rosenberg, Erhard Seiller, Hagen Kruger, Michael Althaus
  • NERAMEXANE FOR THE TREATMENT OR PREVENTION OF TINNITUS RELATED WITH STRESS OR ACUTE HEARING LOSS
    Publication number: 20130296427
    Abstract: Nerarnexane or a pharmaceutically acceptable salt thereof for use in the treatment or prevention of tinnitus, wherein said neramexane or a pharmaceutically acceptable salt thereof is administered to a patient afflicted with tinnitus caused by stress or acute hearing loss.
    Type: Application
    Filed: January 19, 2012
    Publication date: November 7, 2013
    Applicant: MERZ PHARMA GmbH & CO. KGaA
    Inventors: Michael Althaus, Barbara Ellers-Lenz
  • Neramexane for the treatment or prevention of inner ear disorders
    Publication number: 20110294890
    Abstract: The present invention relates to a method of treatment or prevention of an inner ear disorder in a female comprising administering a therapeutically effective amount of neramexane or a pharmaceutically acceptable salt thereof to a female.
    Type: Application
    Filed: May 25, 2011
    Publication date: December 1, 2011
    Applicant: MERZ PHARMA GmbH & CO. KGaA
    Inventors: Michael Althaus, Barbara Ellers-Lenz, Irena Pulte
  • 1-AMINOCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF SLEEP DISORDERS.
    Publication number: 20110207793
    Abstract: The present invention relates to the treatment of an individual afflicted with sleep disorders associated with tinnitus and/or neurological diseases comprising administering to the individual an effective amount of a 1-amino-alkylcyclohexane derivative.
    Type: Application
    Filed: June 10, 2009
    Publication date: August 25, 2011
    Inventors: Barbara Ellers-Lenz, Tanja Rosenberg, Hagen Kruger, Michael Althaus
  • 1-AMINO-ALKYLCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF COGNITIVE IMPAIRMENT IN TINNITUS
    Publication number: 20110178179
    Abstract: The present invention relates to the treatment of an individual afflicted with cognitive impairment associated with tinnitus comprising administering to the individual an effective amount of a 1-amino-alkylcyclohexane derivative.
    Type: Application
    Filed: September 2, 2009
    Publication date: July 21, 2011
    Applicant: MERZ PHARMA GmbH & CO. KGaA
    Inventors: Barbara Ellers-Lenz, Tanja Rosenberg, Roman Görtelmeyer, Hagen Kruger, Michael Althaus
  • INTERVAL THERAPY FOR THE TREATMENT OF TINNITUS
    Publication number: 20110086916
    Abstract: The present invention relates to interval and/or maintenance therapy employing 1-amino-alkylcyclohexane derivatives (e.g., neramexane or a pharmaceutically acceptable salt thereof) for the treatment of an individual afflicted with tinnitus.
    Type: Application
    Filed: September 10, 2008
    Publication date: April 14, 2011
    Applicant: MERZ PHARMA GmbH & CO. KGaA
    Inventors: Barbara Ellers-Lenz, Tanja Rosenberg, Micael Althaus, Herman Russ, Hagen Kruger
  • 1-AMINOCYCLOHEXANE DERIVATIVES FOR THE TREATMENT OF COCHLEAR TINNITUS.
    Publication number: 20110077304
    Abstract: The present invention relates to the treatment of an individual afflicted with cochlear tinnitus comprising administering to the individual an effective amount of a 1-amino-alkylcyclohexane derivative.
    Type: Application
    Filed: September 10, 2008
    Publication date: March 31, 2011
    Applicant: MERZ PHARMA GmbH & Co., KGaA
    Inventors: Barbara Ellers-Lenz, Tanja Rosenberg, Hagen Kruger, Michael Al thaus
  • TITRATION PACKAGE FOR NERAMEXANE AND ITS USE IN THE TREATMENT OF AN INNER EAR DISORDER
    Publication number: 20100298441
    Abstract: The present invention relates to a titration scheme for the administration of a 1-amino-alkylcyclohexane derivative which allows for quick attainment of an effective dose of a 1-amino-alkylcyclohexane derivative while minimizing side effects. The present invention further relates to a titration package for providing a 1-amino-alkylcyclohexane derivative (e.g., neramexane or a pharmaceutically acceptable salt thereof) in at least two different dosages. The present titration scheme/titration package may be useful in the treatment of various diseases, including tinnitus.
    Type: Application
    Filed: September 10, 2008
    Publication date: November 25, 2010
    Applicant: MERZ PHARMA GmbH & CO. KGaA
    Inventors: Barbara Ellers-Lenz, Tanja Rosenberg, Erhard Seiller, Hagen Kruger, Michael Althaus